SCNI Stock Analysis: Buy, Sell, or Hold?
SCNI - Scinai Immunotherapeutics Ltd. American Depositary Shares
$3.22
2.93 (995.24%)
▲
5d:
+1227.84%
30d:
+1203.12%
90d:
+548.41%
WAIT
LOW Confidence
Analysis Updated: Aug 21, 2026 12:00 AM ET
Earnings: Sep 09, 2026
15d
Get Alerted When SCNI Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR BETTER ENTRY: SCNI is 1092.6% above its trading range ($0.27). While momentum could continue, risk/reward favors waiting for a pullback.
⏸️ WAIT FOR BETTER ENTRY: SCNI is 1092.6% above its trading range ($0.27). While momentum could continue, risk/reward favors waiting for a pullback.
In-depth Analysis How we analyze
Valuation Analysis: SCNI is currently trading at $3.22, which is considered extended relative to its 30-day fair value range of $0.24 to $0.27.
Technical Outlook: Technically, SCNI is showing sideways momentum. Immediate support is located at $0.22, while resistance sits at $3.58. The stock is showing strong short-term momentum, up 995.2% recently.
Market Sentiment: SCNI scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $700.00 (+297139.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, SCNI is showing sideways momentum. Immediate support is located at $0.22, while resistance sits at $3.58. The stock is showing strong short-term momentum, up 995.2% recently.
Market Sentiment: SCNI scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $700.00 (+297139.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$0.24 -
$0.27
Company Quality Score
36/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
21.1%
All Signals
- BEARISH: Price significantly overextended (+1092.6% above its trading range)
- BEARISH: Weak technical setup (15/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+995.2%)
- BULLISH: Trading 297139.9% below Wall St target ($700.00)
- WARNING: Composite score 36/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$0.24 -
$0.27
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$0.22
Resistance Level
$3.58
Current Trend
Sideways
Technical data as of
Aug 21, 2026
Fundamental Context
Wall Street Target
$700.00
(+297139.9%)
Revenue Growth (YoY)
-16.6%
Earnings Growth (YoY)
87.2%
Profit Margin
-261.4%
Share & Embed Analysis
Last updated: August 24, 2026 5:28 AM ET
Data refreshes hourly during market hours. Next update: 6:28 AM
Data refreshes hourly during market hours. Next update: 6:28 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SCNI showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$81 | 58 HOLD |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$55 | 57 HOLD |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$92 | 54 HOLD |
|
RCKT
Rocket Pharmaceuticals I… |
STRONG BUY
18 analysts |
$9 | 53 HOLD |
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$88 | 40 SELL |